stoxline Quote Chart Rank Option Currency Glossary
Savara Inc. (SVRA)
4.15  0.07 (1.72%)    05-28 16:00
Open: 4.13
High: 4.17
Volume: 1,067,337
Pre. Close: 4.08
Low: 4
Market Cap: 573(M)
Technical analysis
2024-05-28 4:56:19 PM
Short term     
Mid term     
Targets 6-month :  5.61 1-year :  6.2
Resists First :  4.8 Second :  5.3
Pivot price 4.57
Supports First :  4 Second :  3.32
MAs MA(5) :  4.2 MA(20) :  4.62
MA(100) :  4.78 MA(250) :  4.07
MACD MACD :  -0.2 Signal :  -0.2
%K %D K(14,3) :  5.3 D(3) :  7.6
RSI RSI(14): 39.7
52-week High :  5.69 Low :  2.55
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ SVRA ] has closed above bottom band by 20.5%. Bollinger Bands are 67.2% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 2 days. This is a sign that the current trend might continue.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 4.17 - 4.19 4.19 - 4.21
Low: 3.95 - 3.97 3.97 - 3.99
Close: 4.12 - 4.15 4.15 - 4.18
Company Description

Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.

Headline News

Thu, 23 May 2024
Savara (NASDAQ:SVRA) Trading 3% Higher Following Analyst Upgrade - Defense World

Wed, 22 May 2024
Savara (NASDAQ:SVRA) Price Target Raised to $11.00 at Oppenheimer - Defense World

Tue, 21 May 2024
Savara Inc.'s (NASDAQ:SVRA) Path To Profitability - Yahoo News UK

Sun, 12 May 2024
Short Interest in Savara Inc (NASDAQ:SVRA) Rises By 28.4% - MarketBeat

Tue, 07 May 2024
Do Options Traders Know Something About Savara (SVRA) Stock We Don't? - Yahoo Lifestyle Australia

Fri, 05 Apr 2024
Savara Insiders Sold US$632k Of Shares Suggesting Hesitancy - Simply Wall St

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Stock Basics & Statistics
Shares Out 138 (M)
Shares Float 81 (M)
Held by Insiders 5.6 (%)
Held by Institutions 85.1 (%)
Shares Short 4,300 (K)
Shares Short P.Month 3,700 (K)
Stock Financials
EPS -0.38
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0.87
Profit Margin 0 %
Operating Margin 0 %
Return on Assets (ttm) -30.3 %
Return on Equity (ttm) -58.6 %
Qtrly Rev. Growth 0 %
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) -0.51
Qtrly Earnings Growth 0 %
Operating Cash Flow -60 (M)
Levered Free Cash Flow -35 (M)
Stock Valuations
PE Ratio -11.22
PEG Ratio 0
Price to Book value 4.71
Price to Sales 0
Price to Cash Flow -9.61
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android